Kenya, and Tanzania. [5] [6] [7] The Arabian Gulf countries lie at the fringes of malaria endemicity, and local disease transmission in the area has been interrupted because of sustained vector control. 8 Rigorous control interventions in the 1960-1970s resulted in a malaria-free status for most countries of the GCC, with the exceptions of Saudi Arabia and Yemen. 9 The WHO certification of malaria-free status is indicative of sustained elimination of indigenous malaria transmission for at least three consecutive years. However, the constant influx of imported malaria cases from endemic countries represents a direct threat to the aforementioned success. 10 In Qatar, malaria transmission has been interrupted since the 1970s 7 ; however, the incidence of imported malaria increased more than two-fold in 2005 and 2006 after a lengthy consistent decrease. 11 The majority of cases were male, nonQatari, and aged 15 years or above. Plasmodium vivax was the main etiologic agent in half of the cases, and most incidences occurred between August and October, which confirms the importation of infection from endemic countries during the summer vacation. 11, 12 Hence, the present study recommends that efforts be introduced to educate travelers about malaria prophylaxis and other preventive measures.
Recently, the Ministry of Public Health-Qatar (MOPH) received a total of 493 confirmed malaria cases among travelers. The number of reported cases was found to be higher among the non-Qatari population (98.2%). The gender distribution was considerably higher among male (89.9%) than female travelers (10.1%). 13 The indigenous malaria transmission has been eliminated in Qatar, but the risk of imported malaria still exists due to the large influx of immigrant workers from the Indian subcontinent and Sub-Saharan Africa posing a risk for malaria re-introduction. 7, 11 Additionally, the country is liable to malaria reintroduction because of the presence of two potential malaria vectors Anopheles stephensi and A. multicolor. 14 Malaria is a serious disease with no effective vaccine available yet. 2, 15 Therefore, malaria prevention is vital and consists of protective measures against mosquito bites as well as chemoprophylaxis use. [16] [17] [18] [19] Chemoprophylaxis is one of the main preventive interventions employed in the field of travel medicine to avoid clinical manifestations and protect against the development of severe illness and death. 18 Depending on the level of risk, it may be appropriate to advise no specific interventions, mosquito avoidance measures only, or mosquito avoidance measures plus chemoprophylaxis. 15 It has been demonstrated that malaria infection should be considered in the differential diagnosis of patients presenting with a recent travel history to malaria-endemic countries as well as in patients with fever of unknown origin. 20 To be effective, malaria chemoprophylaxis has to be taken regularly by travelers. In addition, previous studies have shown that poor compliance is a common problem among travelers because of peer pressure to avoid taking the chemoprophylaxis as well as adverse drug reactions. Thus, travel practitioners should be prepared to address the above-mentioned barriers, especially for long-term travelers. Malaria prevention is a complex issue and requires expert, individualized advice from travel medicine specialists. 21, 22 In the era of malaria elimination, the knowledge and practices of health professionals and travelers regarding chemoprophylaxis are important for preventing the reintroduction of malaria. 23 Travel to malaria-endemic regions requires specific preparation to avoid illness. A primary care doctor might serve the aforementioned task, but constantly changing and highly specialized information renders a dedicated travel medicine expert more likely to succeed in handling the individual needs of different travelers as well as their unique travel itineraries. 24 Only a few studies have assessed the knowledge and practice of physicians regarding malaria chemoprophylaxis, and the information relevant to malaria surveillance in Qatar remains inadequate to give a clear epidemiological picture for developing a national malaria control strategy. In addition, the lack of standardized national guidelines on malaria chemoprophylaxis puts the country at risk of such disease and necessitates a robust surveillance system and preparedness to address any potential outbreaks. Thus, in the present study, physicians' knowledge of travel-related malaria chemoprophylaxis in Qatar was assessed in an attempt to stall the potential spread of this deadly infection in the country.
Methods

Study Area
This cross-sectional study was carried out in 2017 at the MoPH, Doha, Qatar. Before the beginning of a national-level workshop at MoPH about travel health, 50 participants from primary health care centers (PHCC), Qatar's Red Crescent Society (QRCS), and Hamad Medical Corporation (HMC) were invited to complete a self-administered questionnaire.
Data Collection
A structured questionnaire was developed to assess the knowledge of physicians regarding malaria chemoprophylaxis use among travelers. The questionnaire was composed of four main sections: the first gathered demographic data, while the rest were related to the knowledge of physicians regarding the risk of malaria during travel, symptomatology of severe malaria, malaria prevention advice for travelers, and chemoprophylaxis among travelers. Moreover, the survey included 14 questions and required approximately 15 minutes to complete. The initial section of the questionnaire elicited general information about the respondents regarding gender, age, specialty, year of practice, and type of employing healthcare facility. After that, participants were asked about any previous training related to travel health. The questionnaire also explored the physicians' knowledge of the hazards imposed by malaria on travelers. Furthermore, the participants' tested areas of knowledge included mode of malaria transmission, travel characteristics associated with malaria cases, symptoms of malaria after return, and Plasmodium antimalarial resistance. Physicians were also asked about malaria prophylaxis, including the administration, indications, contraindications, and type of advice given in relation to specific destinations. The participants had to respond in a true or false format. The survey also questioned physicians on their current practices regarding malaria chemoprophylaxis for travelers.
To develop the questionnaire, the researchers conducted a review of the literature to include previous evidence on travel-related malaria chemoprophylaxis as well as on the knowledge, attitude, and practice of physicians regarding this issue. An English-based questionnaire was reviewed and validated using the face validation method. Afterwards, the questionnaire was piloted for final revisions or alterations.
Sampling
The current study was conducted during a nationwide workshop at the MoPH, Qatar, for physicians from different governmental healthcare organizations. Thus, a convenient sampling technique was employed, in which the attendees were invited to complete a self-administered questionnaire.
Data Analysis
Data was entered into Microsoft Excel, and analysis was carried out in JMP version 10.0 (SAS Institute, USA). Descriptive statistics were employed as appropriate, such as proportions and percentages for categorical variables or means and standard deviations for continuous variables.
All P values less than or equal to 0.05 were considered to be statistically significant.
Results
Demographic Characteristics of the Study Participants
A total of 42 (92%) physicians working in three healthcare institutions participated in the study. The majority of participants were males (65.8%), non-Qataris (85.0%), and lacked training in travel medicine. The demographics of the study participants are summarized in Table 1 , which shows that almost three-quarters (76.2%) of the physicians were employed at the Primary Health Care Corporation (PHCC). Additionally, based on their specialty, about two-thirds (64.3%) of the participants were family medicine physicians and one-fifth (21.43%) were general practitioners. According to the level of education, more than two-thirds (69%) were specialists and a quarter (26.2%) were resident physicians.
Knowledge of the Study Participants Regarding TravelRelated Malaria
The general knowledge of physicians regarding malaria and risk of transmission during travel is shown in Table 2 . The majority of participants knew of the malaria parasite, Plasmodium species, malaria incidence, transmission, and drug-resistance. In addition, the majority (>90%) of surveyed physicians knew about the major features of severe or complicated malaria, such as impaired consciousness or seizures, severely decreased hemoglobin level (less than 8 g/ dL), disseminated intravascular coagulation and spontaneous bleeding, and hemoglobinuria (Table 3) . Table 4 shows the knowledge of physicians regarding vital factors in the prevention of malaria among travelers. Most respondents were knowledgeable about the importance of eliciting a thorough medical history from travelers, especially the itinerary, health condition, duration and nature of the travel. Additionally, the physicians portrayed a good level of knowledge regarding strategies and methods for preventing malaria among travelers of different subgroups. Most physicians had a comprehensive knowledge about malaria prophylaxis for travelers. In addition, most physicians knew about the indications and administration details for several widely used antimalarial agents, such as doxycycline, atovaquone plus proguanil, chloroquine, and mefloquine ( Table 5 ). The participants' knowledge regarding the specific chemoprophylactic regimen for each of the aforementioned antimalarial medications is shown in Table 6 and includes the frequency, pre-travel administration of medication, and post travel intake of chemoprophylaxis.
Discussion
In the era of malaria elimination, knowledge regarding malaria chemoprophylaxis among physicians is vital for preventing any reintroduction of the disease. 23 A primary healthcare provider can be an excellent source of guidance when making decisions concerning chemoprophylaxis. 15 However, in reality, this might not be the case. A study by the CDC found that primary care physicians could not completely prepare their patients in this regard. 25 In the present study, the majority (84%) of physicians working in the different healthcare institutions participated in the survey, which is an excellent response rate and considered satisfactory for reflecting the level of knowledge among physicians in Qatar.
All study participants were physicians, because only physicians are allowed to practice travel medicine in Qatar; however, in the United Kingdom and Taiwan, nurses account for the majority of travel medicine practitioners, 97% and 70%, respectively. 26, 27 In the current study, the majority (85.0%) of participants For areas where P. vivax is the predominant species of malaria parasite present, in addition to mosquito avoidance interventions, primaquine is a good option as a main prophylaxis for those who aren't G6PD deficient.
33 (78.6) 9 (21.4) 0 (0)
did not receive any training in travel health in contrast with participants of studies from Germany and Greece, where 64 and 60 of health professionals were well trained. 28, 29 Furthermore, the present study revealed a good level of knowledge about malaria prophylaxis and the administration of antimalarials among healthcare providers. There was poor knowledge in certain areas, however, attributable to the fact that most participants had not attended any training in travel The atovaquone plus proguanil combination will not protect against hypnozoite-induced episodes of P. vivax or P. ovale malaria.
(66.7)
12 (28.6) 2 (4.7)
The atovaquone plus proguanil combination should not be used as an antimalarial chemoprophylaxis during pregnancy and breast feeding. The effectiveness of the intradermal rabies vaccine is reduced by chloroquine, so it should be given by the intramuscular route. health. This was evident in some of their answers. Only a few doctors were unaware of the five species of Plasmodium, and a similar portion (14.3%) had no knowledge about the risk of malaria transmission, which is highest at dusk and dawn. The average score regarding the general knowledge of malaria in previous studies was more than 80. 30, 31 Additionally, the average correct score on knowledge of anti-malaria prophylaxis ranged from 52.9% to 98.5%. 29 The participants' knowledge about the major features of complicated falciparum malaria in adults was significant as was their knowledge concerning malaria prevention advice for those traveling to endemic areas.
Conclusion
The current study highlighted several competency areas of knowledge among physicians in Qatar regarding malaria prophylaxis and prevention. However, there are still a few knowledge gaps which demand mitigation. National guidelines for malaria prophylaxis and prevention strategies in travelers are needed with the active dissemination of this information among various healthcare workers to maintain a high level of knowledge. Mandatory continuing professional development programs are also necessary in Qatar. Similarly, training provided by recognized travel health institutions would significantly support the practice of travel medicine in
